IER3IP1 mutations cause neonatal diabetes due to impaired proinsulin trafficking

Hossam Montaser,Sonja Leppänen,Eliisa Vähäkangas,Nils Bäck,Alicia Grace,Solja Eurola,Hazem Ibrahim,Väinö Lithovius,Samuel B. Stephens,Tom Barsby,Diego Balboa,Jonna Saarimäki-Vire,Timo Otonkoski
DOI: https://doi.org/10.2337/db24-0119
IF: 7.7
2024-10-25
Diabetes
Abstract:Immediate early response 3 interacting-protein 1 (IER3IP1) is an endoplasmic reticulum resident protein, highly expressed in pancreatic cells and the developing brain cortex. Homozygous mutations in IER3IP1 have been found in individuals with microcephaly and neonatal diabetes, yet the underlying mechanism causing beta cell failure remains unclear. Here, we utilized differentiation of genome edited-stem cells into pancreatic islet cells to elucidate the molecular basis of IER3IP1 neonatal...
endocrinology & metabolism
What problem does this paper attempt to address?